Is there any relationship between actual benefit and added value of drugs and pharmacovigilance alerts?

Por Tavassoli, Neda, Montastruc, Jean-Louis
Publicado em 2009

Psychiatric adverse drug reactions to glucocorticoids in children and adolescents: a much higher risk with elevated doses

Por Tavassoli, Neda, Montastruc-Fournier, Julie, Montastruc, Jean Louis
Publicado em 2008

Reporting rate of adverse drug reactions to the French pharmacovigilance system with three step 2 analgesic drugs: dextropropoxyphene, tramadol and codeine (in combination with par...

Por Tavassoli, Neda, Lapeyre-Mestre, Maryse, Sommet, Agnès, Montastruc, Jean-Louis
Publicado em 2009

Estimation of time devoted to adverse drug reactions assessment in an internal medicine department

Por Tavassoli, Neda, Bagheri, Haleh, Sailler, Laurent, Benkemoun, Philippe, Montastruc, Jean-Louis, Arlet, Philippe
Publicado em 2005